In this study, using a radically different study design—theory-based, targeted discovery from animal experimentation based on the knowledge of the natural history of endometriotic lesions and then validation from human samples, we found that plasma HMGB1, OPN, and HA are promising admissible biomarkers for diagnosing endometriosis. The gene discussed is SPP1; the disease is endometriosis.